Dr Reddys rolls out Sputnik-V vaccine in Indian market; priced at Rs 948 per dose
Dr Reddy’s Laboratories on Friday announced that the first consignment of imported doses of Sputnik-V vaccine was administered in Hyderabad today as part of a limited pilot soft-launch. The consignment of doses that landed in India on May 01, 2021, received regulatory clearance from Central Drugs Laboratory (CDL, Kasauli) on May 13, 2021.
The company stated in its press release to the exchanges that further consignments of imported doses are expected over the upcoming months and in due course, the supply of Sputnik-V vaccine will commence from Indian manufacturing partners. The imported doses are presently priced at Rs 948 + 5 per cent GST per dose, with the possibility of a lower price point when local supply begins.
The company is working closely with its six manufacturing partners in India to fulfil regulatory requirements to ensure a smooth and timely supply. It will work closely with stakeholders in the government and the private sector in India to ensure the widest possible reach of Sputnik-V vaccine as part of the national inoculation effort.
At 1.53 pm on Friday, the shares of Dr Reddy’s Laboratories Limited were trading at Rs 5,218.95, down by 1.57 per cent against a 0.03 per cent decline in the benchmark index. The 52-week high of the company is recorded at Rs 5,514.65 while its 52-week low is Rs 3,613.45 on BSE.